Bank of Nova Scotia
REGN icon

Bank of Nova Scotia’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$131M Buy
249,278
+126,689
+103% +$66.5M 0.27% 63
2025
Q1
$77.7M Buy
122,589
+32,427
+36% +$20.6M 0.17% 103
2024
Q4
$64.2M Sell
90,162
-8,529
-9% -$6.08M 0.11% 142
2024
Q3
$104M Buy
98,691
+2,555
+3% +$2.69M 0.21% 80
2024
Q2
$101M Buy
96,136
+70,928
+281% +$74.5M 0.2% 80
2024
Q1
$24.3M Sell
25,208
-1,940
-7% -$1.87M 0.05% 239
2023
Q4
$23.8M Sell
27,148
-24,320
-47% -$21.4M 0.04% 268
2023
Q3
$42.4M Buy
51,468
+25,722
+100% +$21.2M 0.11% 153
2023
Q2
$18.5M Buy
25,746
+18,055
+235% +$13M 0.05% 216
2023
Q1
$6.32M Sell
7,691
-7,158
-48% -$5.88M 0.02% 347
2022
Q4
$10.7M Sell
14,849
-12,993
-47% -$9.37M 0.03% 339
2022
Q3
$19.2M Sell
27,842
-12,922
-32% -$8.9M 0.06% 228
2022
Q2
$24.1M Buy
40,764
+25,994
+176% +$15.4M 0.06% 250
2022
Q1
$10.3M Sell
14,770
-39,335
-73% -$27.5M 0.02% 443
2021
Q4
$34.2M Sell
54,105
-69,070
-56% -$43.6M 0.05% 281
2021
Q3
$74.5M Sell
123,175
-22,473
-15% -$13.6M 0.13% 144
2021
Q2
$81.4M Buy
145,648
+125,015
+606% +$69.8M 0.15% 127
2021
Q1
$9.76M Buy
20,633
+1,914
+10% +$906K 0.02% 401
2020
Q4
$9.04M Sell
18,719
-39,575
-68% -$19.1M 0.02% 372
2020
Q3
$32.6M Buy
58,294
+45,042
+340% +$25.2M 0.09% 193
2020
Q2
$8.26M Sell
13,252
-51,894
-80% -$32.4M 0.03% 329
2020
Q1
$31.8M Sell
65,146
-25,726
-28% -$12.6M 0.11% 168
2019
Q4
$34.1M Sell
90,872
-31,241
-26% -$11.7M 0.08% 202
2019
Q3
$33.9M Buy
122,113
+100,281
+459% +$27.8M 0.1% 183
2019
Q2
$6.83M Buy
21,832
+4,420
+25% +$1.38M 0.03% 356
2019
Q1
$7.15M Buy
17,412
+791
+5% +$325K 0.03% 361
2018
Q4
$6.21M Buy
16,621
+853
+5% +$319K 0.03% 350
2018
Q3
$6.37M Sell
15,768
-4,797
-23% -$1.94M 0.03% 376
2018
Q2
$7.09M Buy
20,565
+10,750
+110% +$3.71M 0.04% 295
2018
Q1
$3.38M Sell
9,815
-15,438
-61% -$5.31M 0.02% 447
2017
Q4
$9.5M Buy
25,253
+11,909
+89% +$4.48M 0.04% 319
2017
Q3
$5.97M Sell
13,344
-3,843
-22% -$1.72M 0.03% 337
2017
Q2
$8.44M Sell
17,187
-230
-1% -$113K 0.04% 319
2017
Q1
$6.75M Buy
17,417
+13,003
+295% +$5.04M 0.03% 345
2016
Q4
$1.62M Buy
4,414
+2,829
+178% +$1.04M 0.01% 389
2016
Q3
$637K Sell
1,585
-40,358
-96% -$16.2M ﹤0.01% 443
2016
Q2
$14.6M Buy
41,943
+40,478
+2,763% +$14.1M 0.09% 111
2016
Q1
$528K Buy
1,465
+20
+1% +$7.21K ﹤0.01% 427
2015
Q4
$784K Buy
1,445
+8
+0.6% +$4.34K ﹤0.01% 389
2015
Q3
$668K Buy
1,437
+117
+9% +$54.4K ﹤0.01% 339
2015
Q2
$673K Buy
1,320
+61
+5% +$31.1K ﹤0.01% 322
2015
Q1
$568K Sell
1,259
-81
-6% -$36.5K ﹤0.01% 341
2014
Q4
$550K Sell
1,340
-17
-1% -$6.98K ﹤0.01% 346
2014
Q3
$489K Buy
1,357
+100
+8% +$36K ﹤0.01% 366
2014
Q2
$355K Buy
1,257
+125
+11% +$35.3K ﹤0.01% 414
2014
Q1
$340K Buy
1,132
+18
+2% +$5.41K ﹤0.01% 437
2013
Q4
$307K Buy
1,114
+171
+18% +$47.1K ﹤0.01% 459
2013
Q3
$295K Sell
943
-168
-15% -$52.6K ﹤0.01% 417
2013
Q2
$250K Buy
+1,111
New +$250K ﹤0.01% 425